Scientists ID Gene Linked to Aggressive Liver Cancer U.S. News & World Report The gene also can be used to figure out which liver cancer patients might most benefit from experimental drugs that target the cancer's developmental signaling pathways, said Michael Melner, program director of molecular genetics and biochemistry of ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGfwMUFgom1ccKUmEvZUX1E4M1SKw&url=http://www.usnews.com/health-news/news/articles/2013/06/12/scientists-id-gene-linked-to-aggressive-liver-cancer

“This bill seeks to create equity in
the field of medical research compensation by removing the
prohibition on compensation for women participating in oocyte (egg)
donation for medical research. All other research subjects are
compensated for their time, trouble, and inconvenience involved in
participating in research. AB 926 ensures that women are treated
equally to all other research subjects - allowing them to actively
evaluate their participation in research studies. Unfortunately, the
ban on compensation has had serious unintended consequences. It has
led to a de facto prohibition on women’s reproductive research in
California, adversely impacting the same women that the ban intended
to protect. With few oocytes donated, fertility research and
fertility preservation research has been at a standstill. This
greatly affects women suffering from fertility issues and women
facing cancer who would like to preserve their oocytes.”

“Egg harvesting exposes healthy young
women to multiple synthetic hormones in order to produce many times
the normal number of eggs per cycle. One of the potential harms is
OHSS, which has resulted in hospitalizations and at least a few
documented deaths. These groups state that many experts remain
concerned about the long-term risks of these drugs, especially
their potential impact on infertility and various cancers.
Follow-up research on egg providers, which could establish the
frequency and severity of these adverse outcomes, is widely
recognized to be grossly inadequate.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/SVuriAz87l0/compensation-for-human-eggs-approved-by.html

“Furthermore, as a premier
legislative advocacy and (Nielsen's italics) ballot measure
law ?rm, Nielsen Merksamer can actively and effectively assist CIRM
as it contemplates returning to the voters for additional funding.”

“Another unique advantage offered by
Nielsen Merksamer is that, unlike the vast majority of lobbying ?rms,
since we are a full-service law ?rm, our relationships with our
clients are subject to the attorney-client privilege.”

“(N)o one understands CIRM’s 'total
picture' better than Nielsen Merksamer. Not only has Nielsen
Merksamer been representing CIRM before the Legislature for the past
decade, but Nielsen Merksamer was also one of the principal drafters
of the aforementioned Proposition 71—which brought CIRM to life.
The depth of Nielsen Merksamer’s familiarity with, and
understanding of, CIRM’s mission and structure, the challenges it
faces, and the promise it holds simply cannot be matched by any other
legislative advocate.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/kTRN6kUuSDk/merksamer-makes-only-bid-for-stem-cell.html

Stemlogix Stem Cell Therapy Heals Angie the Chimp!
A year ago Stemlogix donated its stem cell technology to veterinarians in Florida to treat a rescue chimpanzee at the "Save The Chimps" facility named Angie. Angie was suffering from an ACL...

By: Stemlogix, LLC

See the rest here:
Stemlogix Stem Cell Therapy Heals Angie the Chimp! - Video

The Alliance for the Advancement of Adult Stem Cell Therapy and Research
Billy Orr is a quadriplegic who spent the last quarter century in a wheelchair. You are watching Billy Orr stand and walk for the first time after having adu...

By: TheStemCellAlliance

See the original post here:
The Alliance for the Advancement of Adult Stem Cell Therapy and Research - Video

MOUNTAIN VIEW, Calif., June 10, 2013 /PRNewswire/ -- SanBio Inc., a California-based regenerative medicine company, announced today that the U.S. Food and Drug Administration has approved their Investigational New Drug application (IND) for the use of SB623, a novel allogeneic stem cell therapy product, in patients suffering from traumatic brain injuries (TBI's). This approval allows the company to proceed with a Phase 1/2a clinical trial testing the safety and feasibility of the therapy. The clinical trial is expected to be carried out at several major hospitals in the United States.

"This is the second clinical program for SanBio," said Keita Mori, SanBio's Chief Executive Officer, "we see this as a clear validation of our development program and a significant broadening of the therapeutic application of our lead product SB623 for the treatment of unaddressed chronic neurological deficits."

"We measure the responses of TBI patients to physical therapy every day. Progress is often painfully slow and incremental," said Dr. Daniel Lu, Principal Investigator, Neuroplasticity and Repair Laboratory and Director, Neuromotor Recovery Research Center, University of California, Los Angeles, "If this new cell therapy approach improves outcomes it could have a dramatic positive effect on many lives."

About Traumatic Brain Injury: According to the Center for Disease Control and Prevention, more the 1.7 million people in the United States sustain a traumatic brain injury each year, resulting in approximately 50,000 deaths and 275,000 hospitalizations. Many of these more severely injured patients suffer permanent disabilities, including loss of motor function and cognitive impairment. Other than physical rehabilitation there is no effective therapy. Direct medical costs and indirect costs such as lost productivity of TBI totaled an estimated $76.5 billion in the United States in 2000.

About SB623: SB623 is a proprietary cell therapy product consisting of cells derived from genetically modified bone marrow stromal cells obtained from healthy adult donors. SB623 is administered adjacent to the damaged area of the brain. SB623 functions by producing factors that aid the regenerative process.

About SanBio: SanBio is a privately held San Francisco Bay Area biotechnology company focused on the discovery and development of new regenerative cell therapy products.

For more information: http://www.san-bio.com

See the rest here:
SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product ...

Howard Hughes Medical Institute

Genetic Engineering Alters Mosquitoes' Sense of Smell Howard Hughes Medical Institute In one of the first successful attempts at genetically engineering mosquitoes, HHMI researchers have altered the way the insects respond to odors, including the smell of humans and the insect repellant DEET. The research not only demonstrates that ... Genetically-engineered mosquitoes lose nose for humansGizmag Genetic Bug Spray? Scientists Alter Mosquitoes' Sense of SmellGenetic Engineering News Mutant Mosquitoes Lose Ability to Sniff Out HumansLiveScience.com all 33 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHbgoghGNV8NlYHGOUfkkveCyQRAg&url=http://www.hhmi.org/news/vosshall20130529.html

Biotechnology: Virtual reality Nature.com Such is life at a 'virtual' biotechnology company, a lean, nimble model that is gaining popularity among cash-hungry start-ups. These companies consist of as few as one full-time employee who oversees a drug from preclinical development to tests in ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNER4iej-_loaP5i-RCk1Pwep-v-Sw&url=http://www.nature.com/nature/journal/v498/n7452/full/nj7452-127a.html

Webinar on Biotechnology Patents at the US Supreme Court Patent Docs Dr. Noonan will discuss these cases and their effects on the biotechnology industry, particularly in view of recent trends at the Supreme Court regarding the scope of patenting, as well as discuss the Supreme Court's decision in Mayo Collaborative ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGUuyj8-RajGPteLUW9Lzgz25d0SA&url=http://www.patentdocs.org/2013/06/webinar-on-biotechnology-patents-at-the-us-supreme-court.html

euronews

Biotechnology to fight air pollution euronews Using biotechnology to fight pollution is the challenge for a European Union research project. Under the spotlight – a specific kind of moss. At the University of Freiburg in Germany, a team of biologists is growing moss, in a controlled environment ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFN7jC8GqMkkqk4naYGxIxmdinvjw&url=http://www.euronews.com/2013/06/03/biotechnology-to-fight-air-pollution/

The Guardian

What happened when I had my genome sequenced The Guardian Howard Jacob, director of the Human and Molecular Genetics Center in Wisconsin shows Carole Cadwalladr how to use the MyGenome app on her iPad. Photograph: Brent Altomare. At the time, I fumed about that. The information is out there and very shortly ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHm2-rbBYHifF6jL0wo7zP4AnR1JA&url=http://www.guardian.co.uk/science/2013/jun/08/genome-sequenced

ScienceAlert

Gene discovery to avoid baby disease ScienceAlert WAIMR's Laboratory for Molecular Genetics, headed by UWA Winthrop Professor Nigel Laing and globally recognised for its research into an inherited condition known as nemaline myopathy, coordinated a worldwide research effort that led to the discovery ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFmYgCKUgdGKmj7IjbGEihYoxgrBA&url=http://www.sciencealert.com.au/news/20130806-24464.html

The A Team: More than a dozen Bainbridge Spartans rise to the top of their class Bainbridge Island Review She intends to double major in molecular genetics and political science and minor in latin. She's even planning for more education after that. “I'm hopefully going to medical school, because I want to be a surgeon,” Papajani said. Her drive is an ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEBasXnQW11Ie7eCc8NPt1wX4P0vA&url=http://www.bainbridgereview.com/news/210625121.html

Regina Leader-Post

Canadian research suggests drug options to mitigate symptoms of deadly Tay ... Regina Leader-Post The work was published in the journal Human Molecular Genetics. Tay-Sachs is a genetic condition that develops in children born to parents who are both carriers of the disease. It is found all over the world, but rates are particularly high among ... Readily-available drugs may reduce devastating symptoms of Tay-Sachs diseaseMedical Xpress all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFv-c91cK0UXpjsmbxQ1jjIe1seWQ&url=http://www.leaderpost.com/health/Canadian%2Bresearch%2Bsuggests%2Bdrug%2Boptions%2Bmitigate%2Bsymptoms%2Bdeadly/8490075/story.html

Circadian Rhythms Play Role In Fighting Off Intestinal Bacterial Infections: Study Huffington Post "Salmonella is a good pathogen to study what happens during infection," Manuela Raffatellu, an assistant professor of microbiology and molecular genetics at the university, said in a statement. "We think these findings may be broadly applicable to ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFPS8pre2r48aJP0r1DGzKOE7h3lQ&url=http://www.huffingtonpost.com/2013/06/06/circadian-rhythm-bacteria-infection-intestines_n_3385739.html

Discovering 1 reason why swarming evolved offers tantalizing clues on how ... EurekAlert (press release) "There are both costs and benefits to swarming and all other behaviors," said Christoph Adami, MSU professor of microbiology and molecular genetics. "The benefits are discussed all the time. But the litmus test is whether a behavior evolves because of ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFJrnuUF-bz7r6gGUycev55mRaEHA&url=http://www.eurekalert.org/pub_releases/2013-06/msu-dor060413.php

“It can’t help but increase the
value of other stem cell companies.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/iGlLbdQVr0Y/light-coverage-of-cellular-dynamics-ipo.html

Jamie Thomson UCSB photo

“During 2011 and 2012, we had three
large biopharmaceutical customers that individually accounted for
greater than 10% of our total revenue in one or both years. Eli Lilly
and Company (Lilly) accounted for 10% of total revenue in 2011 and
18% of total revenue in 2012. Hoffmann-La Roche Inc. (Roche)
accounted for 13% of total revenue in 2011 and GlaxoSmithKline plc
(GSK) accounted for 11% of our total revenue in 2012.”

“Our total revenue grew from $2.6
million in 2011 to $6.6 million in 2012, an increase of 154%. This
growth was driven by a 247% increase in sales of our iCell products
which grew from $1.5 million in 2011 to $5.2 million in 2012. At
December 31, 2011, our backlog of revenue expected to be recognized
in 2012 was $1.1 million. At December 31, 2012, our backlog of
revenue expected to be recognized in 2013 had grown to $4.1 million.

“For the three months ended March 31,
2013 our total revenue was $2.4 million, an increase of 109% over the
corresponding period in 2012. This growth was driven primarily by an
increase in iCell product sales, which grew from $0.6 million for the
three months ended March 31, 2012 to $1.8 million for the three
months ended March 31, 2013, an increase of 173%.”

"A
recent question is the issue of who has the intellectual property
(IP) rights to iPS cell technology. People have told me in the
past that they wondered if Cellular Dynamics has unambiguous rights
to develop all of these iPS cell-based products."

 “This (the IPO) looks to
be very interesting and could transform the field as it develops.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/0oup8hU2FGE/cellular-dynamics-california-stem-cell.html

Claire Pomeroy CIRM photo

“For some children, the uncertainty
of life on the street is better than certainty of violence at home.
It was for me. At age 14, I escaped from an abusive home with no
money, nowhere to go and only the clothes I was wearing. I remember
staring into the night, standing somewhere between fear and freedom.
I became one of the millions of homeless teens, yet I was lucky
because foster care ultimately saved me.”

“However, after an emergency
placement and three foster homes, the challenges were not over. At 17
I aged out of the foster care system early when my foster parents
moved out of state. On my own again, I had to find a job, a place to
live and finish high school. Then I climbed the next mountain to
graduate from college and medical school.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/zancriHTUC4/pomeroy-on-doing-right-thing-and-foster.html

China Daily

Salvation, through avatars China Daily Yet he has the attention, and in some cases the avid support, of august figures at Harvard University and the Massachusetts Institute of Technology and leaders in fields like molecular genetics and neuroprosthetics. Roughly 30 speakers from these and ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHoomaulmFS7XGQkQRsGFnKPASQGQ&url=http://www.chinadaily.com.cn/sunday/2013-06/09/content_16595636.htm